Financhill
Back

Haemonetics Stock Predictions

Haemonetics Stock Forecast

  • Over the next 52 weeks, Haemonetics has on average historically risen by 11.5% based on the past 33 years of stock performance.
  • Haemonetics has risen higher in 18 of those 33 years over the subsequent 52-week period, corresponding to a historical accuracy of 54.55%
  • Is Haemonetics Stock Undervalued?
    The current Haemonetics [HAE] share price is $85.55. The Score for HAE is 72, which is 44% above its historic median score of 50, and infers lower risk than normal.
  • HAE is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.

Will Haemonetics Stock Go Up Next Year?

  • Over the next 52 weeks, Haemonetics has on average historically risen by 11.5% based on the past 33 years of stock performance.

Haemonetics Stock Rating

Buy
72
Haemonetics (HAE) is a Buy

Is Haemonetics overpriced?

  • Haemonetics has risen higher in 18 of those 33 years over the subsequent 52-week period, corresponding to a historical accuracy of 54.55%

Haemonetics Stock Price History

Is HAE stock going to rise?

  • The current trend is moderately bullish and HAE is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NYSE
Country:
United States
Industry:
Health Care Equipment & Supplies
Sector:
Health Care
Type:
stock
Website:
haemonetics.com

52-Week Data

52-Week High:
97.97
52-Week Low:
70.25

Prediction Charts

Market Cap:
4.3B
Price in USD:
85.55
Volume:
481K
Beta:
0.44

Technical Analysis

SMA50:
78.76
SMA100:
80.24
SMA200:
82.02
52-Wk Change:
4.35%

Stock Predictions

  • Is Haemonetics stock public?
    Yes, Haemonetics is a publicly traded company.
  • What is the Haemonetics stock quote today?
    The Haemonetics stock price is 85.55 USD today.
  • How to buy Haemonetics stock online?
    You can buy Haemonetics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Nov-5 73.22 74.98 75.10 73.22
Nov-6 77.46 78.16 78.67 75.47
Nov-7 84.00 86.53 87.50 83.70
Nov-8 87.27 87.42 87.61 84.96
Nov-11 87.59 91.40 91.47 87.53
Nov-12 90.79 93.38 94.99 90.55
Nov-13 93.06 91.78 93.97 91.45
Nov-14 92.25 90.75 92.54 90.72
Nov-15 90.84 89.22 91.43 88.64
Nov-18 89.25 88.17 89.73 88.15
Nov-19 87.00 84.83 87.48 84.76
Nov-20 84.58 84.92 85.33 83.32
Nov-21 85.00 85.43 86.68 84.42
Nov-22 85.50 85.55 86.00 84.50

Haemonetics Earnings

Haemonetics Earnings Report: Per Share Haemonetics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Haemonetics Forecast Revenue Growth

Haemonetics Stock Analysis: Historical quarterly revenues per share for Haemonetics and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.19 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.98 per share, and an increase next year of $0.63 per share.

* Haemonetics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.